NCT06951828View on ClinicalTrials.gov

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

April 30, 2026

Conditions
Healthy Male Subjects
Interventions
BIOLOGICAL

CT-P43

CT-P43, 45 mg in 0.5 ml, a single subcutaneous (SC) injection via auto-injector (AI)

BIOLOGICAL

CT-P43

CT-P43, 45 mg in 0.5 ml, a single subcutaneous (SC) injection via pre-filled syringe (PFS)

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

Sponsors

Lead Sponsor

Celltrion
All Listed Sponsors
lead

Celltrion

INDUSTRY